Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@genomics-online.com

Human CD44 shRNA in Retroviral Vector

This is a CD44 plasmid from OriGene - 4 times cited - with shRNA insert cloned into Retroviral VectorpRS. Insert length: not_set. Transient, Stable expression. Suitable for RNAi. Bacterial selection: Ampicillin.
OriGene
Catalog No. ABIN3656015
Supplier Product No.: tr314080
$874.17
Plus shipping costs $50.00
1 kit
Shipping to: United States
Delivery in 4 to 9 Business Days

Quick Overview for Human CD44 shRNA in Retroviral Vector (ABIN3656015)

Gene

CD44

Application

RNA Interference (RNAi)

Insert

shRNA

Vector

Retroviral Vector

Vector Backbone

pRS

Promoter

U6 Promoter

Bacterial Resistance

Ampicillin

Expression Type

Transient, Stable
  • Species

    Human

    Supplier Product No.

    tr314080

    Supplier

    OriGene

    Purpose

    Pre-designed Hush-29 shRNAs in viral vectors with proven effectiveness for knock-down of Human CD44.

    Brand

    HuSH-29™

    Specificity

    • The HuSH shRNA gene-specific expression cassettes were optimized to include both the termination signal for RNA Pol III and GC content targeted at 50 % to further improve the quality of the gene-specific shRNA expression vectors.
    • One of the four constructs at minimum are guaranteed to produce 70 % or more gene expression knock-down provided a minimum transfection efficiency of 80 % is achieved.

    Characteristics

    • The shRNA gene-specific expression cassettes are prepared using synthetic oligonucleotides.
    • These oligonucleotide sequences were computer designed for optimal suppression of gene expression and minimal off-target effects.
    • All shRNA sequences are verified through DNA sequencing analysis.

    Components

    • Gene-specific shRNA expression pRS vectors, 5 ug plasmid DNA per vial.
    • Four unique constructs per gene.
    • HuSH 29-mer NonEffective Scrambled pRS 5 ug plasmid DNA.

    Selectable Marker

    Puromycin
  • Application Notes

    • Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection.
    • To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples..

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Storage

    4 °C/-20 °C

    Storage Comment

    The dried plasmids can be stored at 4°C. However, once reconstituted with dH2O, the plasmids must be stored at -20°C.
  • Ohmura, Hishiki, Yamamoto, Nakanishi, Kubo, Tsuchihashi, Tamada, Toue, Kabe, Saya, Suematsu: "Impacts of CD44 knockdown in cancer cells on tumor and host metabolic systems revealed by quantitative imaging mass spectrometry." in: Nitric oxide : biology and chemistry / official journal of the Nitric Oxide Society, Vol. 46, pp. 102-13, (2015) (PubMed).

    De Falco, Tamburrino, Ventre, Castellone, Malek, Manié, Santoro: "CD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cells." in: Cancer research, Vol. 72, Issue 6, pp. 1449-58, (2012) (PubMed).

    Dusio, Cardani, Zanobbio, Mantovani, Luchini, Battini, Galli, Diana, Balsari, Rumio: "Stimulation of TLRs by LMW-HA induces self-defense mechanisms in vaginal epithelium." in: Immunology and cell biology, Vol. 89, Issue 5, pp. 630-9, (2011) (PubMed).

    Brazil, Lee, Kolegraff, Nusrat, Parkos, Louis: "Neutrophil migration across intestinal epithelium: evidence for a role of CD44 in regulating detachment of migrating cells from the luminal surface." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 185, Issue 11, pp. 7026-36, (2010) (PubMed).

  • Target

    CD44

    Alternative Name

    CD44
You are here: